Microbiome: Balancing microbial composition through diet
A reciprocal interaction between gut bacteria and gut cells affects protein absorption in the host.
- Institute of Neuroscience, University of Oregon, United States
- Institute of Molecular Biology, University of Oregon, United States
- Humans and the Microbiome Program, CIFAR, Canada
The gut of animals is a complex ecosystem consisting of trillions of bacteria and other microorganisms that are unique to every individual. Infants can inherit their first gut bacteria through vaginal birth and breastfeeding, and the microbiome is later reshaped through diet (Ames et al., 2023).
The gut microbiome helps to break down and enhance the absorption of nutrients like carbohydrates and lipids but the role of gut bacteria in protein absorption is less clear. Previous research has shown that in neonatal mammals and fishes, specialized cells lining the gut, called enterocytes, are essential for absorbing protein (Park et al., 2019). Now, in eLife, Michel Bagnat, John Rawls and colleagues from Duke University, University of North Carolina and University of Alabama at Birmingham – including Laura Childers as first author – report how microbes affect protein absorption by enterocytes (Childers et al., 2024).
To follow the fate of proteins in a living organism, Childers et al. used transparent zebrafish larvae to visualize fluorescent proteins in their journey through the gut. The team fed the zebrafish fluorescent protein and isolated all the lysosome-rich enterocytes, or LREs, that took up the glowing cargo, and which had been previously shown to take up protein efficiently. They used various techniques to manipulate zebrafish microbiomes. Fish either had a complete gut microbiome (called conventionally reared) or no gut microbiome (germ-free): germ-free animals were further inoculated with single bacterial strains to generate fish with only one type of bacteria in their gut. These monoassociated fish allowed the researchers to measure precisely how specific bacteria affected protein uptake in the zebrafish gut. They then looked at gene expression in each of these different scenarios.
The results showed that collectively, resident microbes slowed down protein uptake and degradation in LREs. Moreover, the LREs in conventionally reared fish upregulated genes involved in immune responses and bacteria-sensing and downregulated genes linked to the degradation of proteins. To identify the impact of specific bacteria on LREs, Childers et al. tracked the fates of the fluorescent proteins in monoassociated fish and identified a bacterial strain, Acinetobacter calcoaceticus, which only slightly reduced protein uptake compared to germ-free fish, while the Vibrio cholerae strain significantly decreased how much protein the LREs absorbed.
To explore why the fish colonized by V. cholerae absorbed protein so poorly, Childers et al. analyzed the protein uptake machinery of LREs. This revealed that expression of genes encoding the protein uptake machinery in V. cholerae monoassociated fish were reduced compared to A. calcoaceticus-monoassociated or germ-free animals. Why the expression of these genes changed in the presence of different bacteria remains to be determined. The V. cholerae strain used can cause a lot of damage to enterocytes (Ngo et al., 2024). It is possible that LREs down-regulate protein uptake in the presence of harmful bacteria like V. cholerae to avoid taking up toxic proteins. Alternatively, the LREs of V. cholerae-colonized fish may simply be slightly impaired and less capable of protein uptake. This suggests that individual bacterial strains can influence how much protein gets absorbed by enterocytes.
Childers et al. also explored how the amount of protein remaining in the gut tube affected the composition of the gut microbiome. When they fed zebrafish a low protein diet in comparison to the normal diet, they noted significant shifts in the types of bacteria found in the gut, especially in mutant zebrafish with defects in their protein uptake machinery. Fish fed a low protein diet had less diverse microbiomes.
Understanding what regulates the protein uptake machinery will shed new light on diseases of malnutrition. For example, children with kwashiorkor disease suffer from protein malabsorption (Williams, 2003). Their gut microbiomes appear to play a role in the disease because feces from children with kwashiorkor can cause similar symptoms when introduced into germ-free mice (Smith et al., 2013). Perhaps the gut bacteria of kwashiorkor patients inhibit protein uptake similarly to V. cholerae in zebrafish.
Childers et al. show that gut microbes shape the fate of protein in the gut. Future research will explore how specific bacteria affect the protein uptake machinery and how protein availability in the gut affects the microbiome. Already, the findings support the idea that correcting defective microbiomes could be a promising strategy for treating childhood malnutrition (Barratt et al., 2022). The findings also offer a cautionary lesson: dramatically changing the protein content of your diet, for example by consuming protein shakes, could backfire by changing the microbiome, possibly in a way that impairs protein uptake processes in the gut.
References
-
Gut microbiome development and childhood undernutritionCell Host & Microbe 30:617–626.https://doi.org/10.1016/j.chom.2022.04.002
-
Kwashiorkor: a nutritional disease of children associated with a maize diet. 1935Bulletin of the World Health Organization 81:912–913.
Article and author information
Author details
Publication history
Copyright
© 2024, Acuff and Guillemin
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 710
- views
-
- 73
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Microbiome: Balancing microbial composition through diet
eLife 13:e104560.
https://doi.org/10.7554/eLife.104560
Further reading
-
- Cell Biology
Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.
-
- Cell Biology
Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.
